ijms-logo

Journal Browser

Journal Browser

Regulation of Ubiquitin Family Signaling in Disease

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: closed (28 February 2023) | Viewed by 22870

Special Issue Editor


E-Mail Website
Guest Editor
Department of Physiological Sciences, University of Barcelona, 08907 L’Hospitalet de Llobregat (Barcelona), Spain
Interests: HERC; HECT; ubiquitin; MAPK; RAF; p53; NEURL4; ubiquitylation and cell signaling
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

We are organizing a Special Issue of the International Journal of Molecular Sciences (IJMS) (Impact Factor: 5.923 (2020 JCR), Q1 in "Biochemistry & Molecular Biology") focused on the “Regulation of Ubiquitin Family Signaling in Disease”.

Proteins are regulated by the conjugation of ubiquitin or ubiquitin-like proteins. While a synchronized cascade of three enzyme classes (E1, E2, and E3) is responsible for conjugation, deubiquitinating enzymes (DUBs) are the proteases that remove ubiquitin or ubiquitin-like molecules. This post-translational modification marks proteins by regulating their cellular functions, including their degradation, through the proteasome or the autophagy/lysosome pathway. Thus, ubiquitination/ubiquitin-like modifications have been involved in the regulation of important cellular processes such as cell proliferation, cell differentiation, DNA damage repair, cell cycle, apoptosis, signal transduction, and vesicle traffic, among others. Dysregulation of the conjugation process has been associated with multiple diseases such as neurodegeneration, cancer, viral infections, and inflammation. Understanding the molecular mechanisms involved in all these processes and their regulation is crucial to identify potential targets for the therapeutic treatment of associated diseases.

This Special Issue attempts to provide an update of the knowledge in the field of ubiquitin family regulation and its association with diseases. As leading researchers in this field, we would like your participation.

We would like to invite you to submit an original research article or a review paper for this Special Issue.

We appreciate your consideration and sincerely hope you will accept our invitation.

Thank you very much.

Prof. Dr. Jose Luis Rosa
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • ubiquitin
  • SUMO
  • NEDD8
  • ISG15
  • FAT10
  • ubiquitin-like proteins
  • autophagy
  • proteasome

Published Papers (8 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

Jump to: Research, Review

3 pages, 187 KiB  
Editorial
Regulation of Ubiquitin Family Signaling in Disease
by Jose Luis Rosa
Int. J. Mol. Sci. 2023, 24(7), 6735; https://doi.org/10.3390/ijms24076735 - 4 Apr 2023
Viewed by 860
Abstract
Ubiquitin is a small regulatory protein found in all eukaryotic cells [...] Full article
(This article belongs to the Special Issue Regulation of Ubiquitin Family Signaling in Disease)

Research

Jump to: Editorial, Review

20 pages, 3568 KiB  
Article
The Deubiquitinating Enzyme USP48 Interacts with the Retinal Degeneration-Associated Proteins UNC119a and ARL3
by Laura Sánchez-Bellver, Andrea Férriz-Gordillo, Marc Carrillo-Pz, Laura Rabanal, Francesc R. Garcia-Gonzalo and Gemma Marfany
Int. J. Mol. Sci. 2022, 23(20), 12527; https://doi.org/10.3390/ijms232012527 - 19 Oct 2022
Cited by 3 | Viewed by 2177
Abstract
Proteins related to the ubiquitin-proteasome system play an important role during the differentiation and ciliogenesis of photoreceptor cells. Mutations in several genes involved in ubiquitination and proteostasis have been identified as causative of inherited retinal dystrophies (IRDs) and ciliopathies. USP48 is a deubiquitinating [...] Read more.
Proteins related to the ubiquitin-proteasome system play an important role during the differentiation and ciliogenesis of photoreceptor cells. Mutations in several genes involved in ubiquitination and proteostasis have been identified as causative of inherited retinal dystrophies (IRDs) and ciliopathies. USP48 is a deubiquitinating enzyme whose role in the retina is still unexplored although previous studies indicate its relevance for neurosensory organs. In this work, we describe that a pool of endogenous USP48 localises to the basal body in retinal cells and provide data that supports the function of USP48 in the photoreceptor cilium. We also demonstrate that USP48 interacts with the IRD-associated proteins ARL3 and UNC119a, and stabilise their protein levels using different mechanisms. Our results suggest that USP48 may act in the regulation/stabilisation of key ciliary proteins for photoreceptor function, in the modulation of intracellular protein transport, and in ciliary trafficking to the photoreceptor outer segment. Full article
(This article belongs to the Special Issue Regulation of Ubiquitin Family Signaling in Disease)
Show Figures

Figure 1

14 pages, 2302 KiB  
Article
UDP-Glucose: A Cereblon-Dependent Glucokinase Protein Degrader
by Jaeyong Cho, Atsushi Miyagawa, Kazuki Yamaguchi, Wakana Abe, Yoji Tsugawa, Hatsuo Yamamura and Takeshi Imai
Int. J. Mol. Sci. 2022, 23(16), 9094; https://doi.org/10.3390/ijms23169094 - 13 Aug 2022
Cited by 4 | Viewed by 3540
Abstract
We previously reported that glucokinase is ubiquitinated and degraded by cereblon with an unknown endogenous glucokinase protein degrader. Here, we show that UDP-glucose is a glucokinase protein degrader. We identified that both glucose and UDP-glucose bind to glucokinase and that both uridine and [...] Read more.
We previously reported that glucokinase is ubiquitinated and degraded by cereblon with an unknown endogenous glucokinase protein degrader. Here, we show that UDP-glucose is a glucokinase protein degrader. We identified that both glucose and UDP-glucose bind to glucokinase and that both uridine and UDP-glucose bind to cereblon in a similar way to thalidomide. From these results, UDP-glucose was identified as a molecular glue between cereblon and glucokinase. Glucokinase produces glucose-6-phosphate in the pancreas and liver. Especially in β-cells, glucokinase is the main target of glucose for glucose-induced insulin secretion. UDP-glucose administration ubiquitinated and degraded glucokinase, lowered glucose-6-phosphate production, and then reduced insulin secretion in β-cell lines and mice. Maturity-onset diabetes of the young type 2 (MODY2) glucokinaseE256K mutant protein was resistant to UDP-glucose induced ubiquitination and degradation. Taken together, glucokinase ubiquitination and degradation signaling might be impaired in MODY2 patients. Full article
(This article belongs to the Special Issue Regulation of Ubiquitin Family Signaling in Disease)
Show Figures

Figure 1

21 pages, 4471 KiB  
Article
Membrane Targeting and GTPase Activity of Rab7 Are Required for Its Ubiquitination by RNF167
by Kim Ghilarducci, Valérie C. Cabana, Ali Harake, Laurent Cappadocia and Marc P. Lussier
Int. J. Mol. Sci. 2022, 23(14), 7847; https://doi.org/10.3390/ijms23147847 - 16 Jul 2022
Cited by 3 | Viewed by 2259
Abstract
Rab7 is a GTPase that controls late endosome and lysosome trafficking. Recent studies have demonstrated that Rab7 is ubiquitinated, a post-translational modification mediated by an enzymatic cascade. To date, only one ubiquitin E3 ligase and one deubiquitinase have been identified in regulating Rab7 [...] Read more.
Rab7 is a GTPase that controls late endosome and lysosome trafficking. Recent studies have demonstrated that Rab7 is ubiquitinated, a post-translational modification mediated by an enzymatic cascade. To date, only one ubiquitin E3 ligase and one deubiquitinase have been identified in regulating Rab7 ubiquitination. Here, we report that RNF167, a transmembrane endolysosomal ubiquitin ligase, can ubiquitinate Rab7. Using immunoprecipitation and in vitro ubiquitination assays, we demonstrate that Rab7 is a direct substrate of RNF167. Subcellular fractionation indicates that RNF167 activity maintains Rab7′s membrane localization. Epifluorescence microscopy in HeLa cells shows that Rab7-positive vesicles are larger under conditions enabling Rab7 ubiquitination by RNF167. Characterization of its ubiquitination reveals that Rab7 must be in its GTP-bound active form for membrane anchoring and, thus, accessible for RNF167-mediated ubiquitin attachment. Cellular distribution analyses of lysosome marker Lamp1 show that vesicle positioning is independent of Rab7 and RNF167 expression and that Rab7 endosomal localization is not affected by RNF167 knockdown. However, both Rab7 and RNF167 depletion affect each other’s lysosomal localization. Finally, this study demonstrates that the RNF167-mediated ubiquitination of Rab7 GTPase is impaired by variants of Charcot–Marie–Tooth Type 2B disease. This study identified RNF167 as a new ubiquitin ligase for Rab7 while expanding our knowledge of the mechanisms underlying the ubiquitination of Rab7. Full article
(This article belongs to the Special Issue Regulation of Ubiquitin Family Signaling in Disease)
Show Figures

Figure 1

Review

Jump to: Editorial, Research

16 pages, 2041 KiB  
Review
Regulation of MAPK Signaling Pathways by the Large HERC Ubiquitin Ligases
by Joan Sala-Gaston, Laura Costa-Sastre, Leonardo Pedrazza, Arturo Martinez-Martinez, Francesc Ventura and Jose Luis Rosa
Int. J. Mol. Sci. 2023, 24(5), 4906; https://doi.org/10.3390/ijms24054906 - 3 Mar 2023
Cited by 3 | Viewed by 2177
Abstract
Protein ubiquitylation acts as a complex cell signaling mechanism since the formation of different mono- and polyubiquitin chains determines the substrate’s fate in the cell. E3 ligases define the specificity of this reaction by catalyzing the attachment of ubiquitin to the substrate protein. [...] Read more.
Protein ubiquitylation acts as a complex cell signaling mechanism since the formation of different mono- and polyubiquitin chains determines the substrate’s fate in the cell. E3 ligases define the specificity of this reaction by catalyzing the attachment of ubiquitin to the substrate protein. Thus, they represent an important regulatory component of this process. Large HERC ubiquitin ligases belong to the HECT E3 protein family and comprise HERC1 and HERC2 proteins. The physiological relevance of the Large HERCs is illustrated by their involvement in different pathologies, with a notable implication in cancer and neurological diseases. Understanding how cell signaling is altered in these different pathologies is important for uncovering novel therapeutic targets. To this end, this review summarizes the recent advances in how the Large HERCs regulate the MAPK signaling pathways. In addition, we emphasize the potential therapeutic strategies that could be followed to ameliorate the alterations in MAPK signaling caused by Large HERC deficiencies, focusing on the use of specific inhibitors and proteolysis-targeting chimeras. Full article
(This article belongs to the Special Issue Regulation of Ubiquitin Family Signaling in Disease)
Show Figures

Figure 1

37 pages, 1622 KiB  
Review
Ubiquitin-Specific Proteases (USPs) and Metabolic Disorders
by Hiroshi Kitamura
Int. J. Mol. Sci. 2023, 24(4), 3219; https://doi.org/10.3390/ijms24043219 - 6 Feb 2023
Cited by 15 | Viewed by 4972
Abstract
Ubiquitination and deubiquitination are reversible processes that modify the characteristics of target proteins, including stability, intracellular localization, and enzymatic activity. Ubiquitin-specific proteases (USPs) constitute the largest deubiquitinating enzyme family. To date, accumulating evidence indicates that several USPs positively and negatively affect metabolic diseases. [...] Read more.
Ubiquitination and deubiquitination are reversible processes that modify the characteristics of target proteins, including stability, intracellular localization, and enzymatic activity. Ubiquitin-specific proteases (USPs) constitute the largest deubiquitinating enzyme family. To date, accumulating evidence indicates that several USPs positively and negatively affect metabolic diseases. USP22 in pancreatic β-cells, USP2 in adipose tissue macrophages, USP9X, 20, and 33 in myocytes, USP4, 7, 10, and 18 in hepatocytes, and USP2 in hypothalamus improve hyperglycemia, whereas USP19 in adipocytes, USP21 in myocytes, and USP2, 14, and 20 in hepatocytes promote hyperglycemia. In contrast, USP1, 5, 9X, 14, 15, 22, 36, and 48 modulate the progression of diabetic nephropathy, neuropathy, and/or retinopathy. USP4, 10, and 18 in hepatocytes ameliorates non-alcoholic fatty liver disease (NAFLD), while hepatic USP2, 11, 14, 19, and 20 exacerbate it. The roles of USP7 and 22 in hepatic disorders are controversial. USP9X, 14, 17, and 20 in vascular cells are postulated to be determinants of atherosclerosis. Moreover, mutations in the Usp8 and Usp48 loci in pituitary tumors cause Cushing syndrome. This review summarizes the current knowledge about the modulatory roles of USPs in energy metabolic disorders. Full article
(This article belongs to the Special Issue Regulation of Ubiquitin Family Signaling in Disease)
Show Figures

Graphical abstract

20 pages, 1497 KiB  
Review
NEDD4 E3 Ligases: Functions and Mechanisms in Bone and Tooth
by Ke Xu, Yanhao Chu, Qin Liu, Wenguo Fan, Hongwen He and Fang Huang
Int. J. Mol. Sci. 2022, 23(17), 9937; https://doi.org/10.3390/ijms23179937 - 1 Sep 2022
Cited by 4 | Viewed by 2374
Abstract
Protein ubiquitination is a precisely controlled enzymatic cascade reaction belonging to the post-translational modification of proteins. In this process, E3 ligases catalyze the binding of ubiquitin (Ub) to protein substrates and define specificity. The neuronally expressed developmentally down-regulated 4 (NEDD4) subfamily, belonging to [...] Read more.
Protein ubiquitination is a precisely controlled enzymatic cascade reaction belonging to the post-translational modification of proteins. In this process, E3 ligases catalyze the binding of ubiquitin (Ub) to protein substrates and define specificity. The neuronally expressed developmentally down-regulated 4 (NEDD4) subfamily, belonging to the homology to E6APC terminus (HECT) class of E3 ligases, has recently emerged as an essential determinant of multiple cellular processes in different tissues, including bone and tooth. Here, we place special emphasis on the regulatory role of the NEDD4 subfamily in the molecular and cell biology of osteogenesis. We elucidate in detail the specific roles, downstream substrates, and upstream regulatory mechanisms of the NEDD4 subfamily. Further, we provide an overview of the involvement of E3 ligases and deubiquitinases in the development, repair, and regeneration of another mineralized tissue—tooth. Full article
(This article belongs to the Special Issue Regulation of Ubiquitin Family Signaling in Disease)
Show Figures

Figure 1

35 pages, 1631 KiB  
Review
Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases
by Nieves Lara-Ureña, Vahid Jafari and Mario García-Domínguez
Int. J. Mol. Sci. 2022, 23(14), 8012; https://doi.org/10.3390/ijms23148012 - 20 Jul 2022
Cited by 11 | Viewed by 3408
Abstract
SUMOylation is a post-translational modification that has emerged in recent decades as a mechanism involved in controlling diverse physiological processes and that is essential in vertebrates. The SUMO pathway is regulated by several enzymes, proteases and ligases being the main actors involved in [...] Read more.
SUMOylation is a post-translational modification that has emerged in recent decades as a mechanism involved in controlling diverse physiological processes and that is essential in vertebrates. The SUMO pathway is regulated by several enzymes, proteases and ligases being the main actors involved in the control of sumoylation of specific targets. Dysregulation of the expression, localization and function of these enzymes produces physiological changes that can lead to the appearance of different types of cancer, depending on the enzymes and target proteins involved. Among the most studied proteases and ligases, those of the SENP and PIAS families stand out, respectively. While the proteases involved in this pathway have specific SUMO activity, the ligases may have additional functions unrelated to sumoylation, which makes it more difficult to study their SUMO-associated role in cancer process. In this review we update the knowledge and advances in relation to the impact of dysregulation of SUMO proteases and ligases in cancer initiation and progression. Full article
(This article belongs to the Special Issue Regulation of Ubiquitin Family Signaling in Disease)
Show Figures

Figure 1

Back to TopTop